Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 182 results for "dpco"

CPA approaches state govt to empower drug inspectors in Chhati...

Against the backdrop of rampant violations of of Drug Price Control Order (DPCO) and Drug and Magic Remedies (DMR) Act, Chattisgarh Pharmacy Association (CPA) has demanded more powers for drug inspectors in Chhatisgarh for effective enforcement ... PharmaBiz, 7 hours ago

3 images for "dpco"

Business 2 Community, 1 week ago
Indiatimes, 2 weeks ago
Business Standard India, 6 months ago

Pharma SMEs may cut contract manufacturing of DPCO drugs

Likely to focus on exports, nutraceutical and cosmoceutical space to offset pressure on margins
 Business Standard4 days ago Pharma SMEs may cut down contract manufacturing of DPCO drugs  Business Standard India1 week ago KDPMA upset over price cuts of 108 drugs; insists govt to take industry into confidence  PharmaBiz3 days ago


National Pharmaceutical Pricing Authority, early this month, brought 108 essential drugs more under the ambit of Drug Price Control Order, 2013 in addition to 348 drugs already under price control. These newly included drugs belong to 8 therapeutic ...
 PharmaBiz6 days ago NPPA's recent notification extends beyond the mandate of DPCO 2013: OPPI  PharmaBiz1 week ago NPPA issues guidelines for stoppage of scheduled formulations under para 21(2) of DPCO, 2013  PharmaBiz1 week ago Drug cos move Bombay HC challenging NPPA's July 10 notification over price control  PharmaBiz3 days ago
India Today

'Price to retailer' only basis for deciding ceiling price of a drug under DPCO: DoP

The Department of Pharmaceuticals (DoP) has clarified to the pharmaceutical industry that the Drugs Price Control Order (DPCO) 2013 does not distinguish between sales of medicines through retailer shop or through hospital outlets while deciding the ...
 PharmaBiz2 weeks ago Pharma producers perturbed by expanded essential medicines list  The Hindu2 weeks ago MODIFYING DPCO 2013  PharmaBiz3 weeks ago Top pharma companies under scanner for selling medicines at high rates  India Today5 days ago

FICCI seeks health minister's intervention to sort out issues arising out of implementation of DPCO 2013

The Federation of Indian Chamber of Commerce and Industry (FICCI) has sought the new Union health minister's intervention to sort out several issues arising out of the implementation of Drug Price Control Order (DPCO) 2013. FICCI also asked the ...
 PharmaBiz1 month ago FICCI presents pharma wish list to the Union Minister of Health & Family Welfare  Express Pharma1 month ago

Bangalore District Chemists & Druggists Assn approaches new govt seeking revision of DPCO 2013

Bangalore District Chemists and Druggists Association is now pressing the newly formed Ministry of Chemicals and Fertilizers to take a re-look at the new Drug Price Control Order(DPCO) 2013 to revise the trade margins among other issues. The ...
 PharmaBiz1 month ago

NPPA's unilateral stand-off unhealthy for sector: Biocon

CII National Committee on Biotechnology Chairperson and Biocon CMD Kiran Mazumdar Shaw has written an open letter to the Prime Minister, seeking his intervention over "unilateral fixing" of drug prices by NPPA . The government has to behave like ...
 Moneycontrol.com16 hours ago

Buy Glenmark Pharma; target of Rs 725: Religare Capital

Religare Capital`s research report on Glenmark Pharma US sales affected by fewer launches; branded businesses shine: Sales growth was driven by branded businesses in India/RoW/Latam (up 21/21/34%), while the US business (up 2% in US$) suffered from ...
 Moneycontrol.com20 hours ago

Pharma firms go to court over new price controls

Major Indian pharmaceutical companies have filed a petition in the High Court in Mumbai protesting the price cuts ordered by the National Pharmaceutical Pricing Authority (NPPA) a fortnight back, which they feel would be detrimental to industry ...
 The Hindu2 days ago

Expect 12-15% growth from US market in FY15: Glenn Saldanha

In an interview with ET Now, Glenn Saldanha, CMD, Glenmark Pharma, shares his business outlook. Excerpts: ET Now: Let us start with the numbers. Market and street had factored in a 15% growth as there were no new launches in the quarter gone by, ...
 Economic Times2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less